Comorbidity in real clinical practice - the patient with gout, cardiovascular disease and kidney damage
https://doi.org/10.21886/2712-8156-2021-2-3-112-117
Abstract
In real clinical practice more and more often doctors treat comorbid patients. The high prevalence of cardiovascular diseases with various comorbid conditions contributes to the progressive increase in the number of patients with a concurrence of several diseases. A comorbid patient is a serious problem for any clinician, since in this case it is necessary to take into account several components of therapy, which makes it difficult to control treatment efficiency, contributes to an increase in polypharmacy, the risk of local and systemic side effects of drugs, and reduces adherence to therapy. A comorbid patient is a serious problem for any clinician. The paper describes and discusses the clinical case of a comorbid patient, who admitted to the cardiological department initially but he had also rheumatological problems (gout), kidney affection.
About the Authors
N. A. KoshelevaRussian Federation
Natalya A. Kosheleva, Lecturer
Saratov
N. A. Magdeeva
Russian Federation
Nadezda A. Magdeeva, Lecturer
Saratov
References
1. Мареев В.Ю., Выгодин В.А., Беленков Ю.Н. ДиУретическая терапия Эффективными дозами перораЛЬных диуретиков торасемида (Диувер®) и фуросемида в лечении больных с обострением Хронической Сердечной Недостаточности (ДУЭЛЬ-ХСН). Журнал Сердечная Недостаточность. 2011;12 (1):3–10. eLIBRARY ID: 17782759
2. Kidney Disease: Improving Global Outcomes (KDIGO) CKDMBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009;(113):S1-130. doi: 10.1038/ki.2009.188. PMID: 19644521.
3. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardio- logy (ESC) Developed with the special contribution of the Heart Fail- ure Association (HFA) of the ESC. European Journal of Heart Failure. 2016;18 (8):891–975. DOI: 10.1002/ejhf. 592
4. Bardin T. Hyperuricemia starts at 360 micromoles (6 mg/ dL). Joint Bone Spine. 2015;82(3):141-3. DOI: 10.1016/j.jbspin.2015.01.002
5. Резник Е.В., Никитин И.Г. Кардиоренальный синдром у больных с сердечной недостаточностью как этап кардиоренального континуума (часть i): определение, классификация, патогенез, диагностика, эпидемиология (обзор литературы). Архивъ внутренней медицины. 2019;9(1):5-22. DOI: 10.20514/2226-6704-2019-9-1-5-22
Supplementary files
Review
For citations:
Kosheleva N.A., Magdeeva N.A. Comorbidity in real clinical practice - the patient with gout, cardiovascular disease and kidney damage. South Russian Journal of Therapeutic Practice. 2021;2(3):112-117. (In Russ.) https://doi.org/10.21886/2712-8156-2021-2-3-112-117